REPROCELL invests in Histocell, S.L. a Spain-based CDMO

Yokohama Japan, 23 November 2022: REPROCELL Inc. decided to invest in Histocell S.L. to strengthen its clinical induced pluripotent stem cell (iPSC) service offerings. Histocell is a CDMO based in Bilbao, Spain, with an authorized Advanced Therapy Medical Product (ATMP) manufacturing facility that offers GMP-grade manufacturing services for cell therapy products. Histocell also develops its own…

Bioserve India granted NABL accreditation in the field of Genomics Testing

Hyderabad, India, 3 August 2022: We are pleased to announce that Bioserve Biotechnologies India Pvt Ltd, a subsidiary of REPROCELL Inc, has received NABL (National Accreditation Board for Testing and Calibration Laboratories) Accreditation for Medical Testing in field of Genomics Testing Services. The accreditation is in accordance with ISO 15189 : 2012 “Medical laboratories –…